Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|December 30, 2009
Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myelomaDon M Benson, Kathryn Panzner, Mehdi Hamadani, et al.
Best Practice & Research. Clinical Haematology|June 23, 2023
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor programRafeek A Yusuf, Jaime M Preussler, Christa L Meyer, et al.
Leukemia & Lymphoma|August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomasMehdi Hamadani, Don M Benson, Craig C Hofmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2013
FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcomeShun He, Jianhong Chu, Sumithira Vasu, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2016
Practice Patterns and Preferences Among Hematopoietic Cell Transplantation CliniciansWilliam A Wood, Margaret K McGinn, Doug Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationThomas Fong, Kathryn Trinkaus, Douglas Adkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.
Blood Advances|April 10, 2023
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemicSteven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|December 30, 2009
Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myelomaDon M Benson, Kathryn Panzner, Mehdi Hamadani, et al.
Best Practice & Research. Clinical Haematology|June 23, 2023
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor programRafeek A Yusuf, Jaime M Preussler, Christa L Meyer, et al.
Leukemia & Lymphoma|August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomasMehdi Hamadani, Don M Benson, Craig C Hofmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2013
FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcomeShun He, Jianhong Chu, Sumithira Vasu, et al.
Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2016
Practice Patterns and Preferences Among Hematopoietic Cell Transplantation CliniciansWilliam A Wood, Margaret K McGinn, Doug Wilson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationThomas Fong, Kathryn Trinkaus, Douglas Adkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.
Blood Advances|April 10, 2023
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemicSteven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, et al.
Pageof 18